Aprotinin treatment against SARS‐CoV‐2: A randomized phase III study to evaluate the safety and efficacy of a pan‐protease inhibitor for moderate COVID‐19 - Redondo‐Calvo - 2022 - European Journal of Clinical Investigation -
Bea (She/Her) (@BeaMoyaFigueroa) / Twitter
Tiendas Justo Muñoz – Juguetes, Deporte y Hogar
10 Colombian Artists Who Are Shaping Contemporary Art | Artsy